1. Home
  2. VCEL vs MBIN Comparison

VCEL vs MBIN Comparison

Compare VCEL & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • MBIN
  • Stock Information
  • Founded
  • VCEL 1989
  • MBIN 1990
  • Country
  • VCEL United States
  • MBIN United States
  • Employees
  • VCEL N/A
  • MBIN N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • MBIN Major Banks
  • Sector
  • VCEL Health Care
  • MBIN Finance
  • Exchange
  • VCEL Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • VCEL 2.1B
  • MBIN 2.0B
  • IPO Year
  • VCEL 1997
  • MBIN 2017
  • Fundamental
  • Price
  • VCEL $41.49
  • MBIN $33.26
  • Analyst Decision
  • VCEL Strong Buy
  • MBIN Buy
  • Analyst Count
  • VCEL 8
  • MBIN 3
  • Target Price
  • VCEL $61.75
  • MBIN $47.50
  • AVG Volume (30 Days)
  • VCEL 547.9K
  • MBIN 180.4K
  • Earning Date
  • VCEL 05-08-2025
  • MBIN 04-28-2025
  • Dividend Yield
  • VCEL N/A
  • MBIN 1.21%
  • EPS Growth
  • VCEL 521.85
  • MBIN N/A
  • EPS
  • VCEL 0.05
  • MBIN 5.44
  • Revenue
  • VCEL $238,541,000.00
  • MBIN $621,412,000.00
  • Revenue This Year
  • VCEL $23.23
  • MBIN $0.85
  • Revenue Next Year
  • VCEL $24.41
  • MBIN $10.33
  • P/E Ratio
  • VCEL $698.68
  • MBIN $6.08
  • Revenue Growth
  • VCEL 14.80
  • MBIN 7.58
  • 52 Week Low
  • VCEL $37.39
  • MBIN $27.25
  • 52 Week High
  • VCEL $63.00
  • MBIN $53.27
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 49.55
  • MBIN 53.16
  • Support Level
  • VCEL $37.48
  • MBIN $29.87
  • Resistance Level
  • VCEL $44.41
  • MBIN $33.48
  • Average True Range (ATR)
  • VCEL 1.86
  • MBIN 1.53
  • MACD
  • VCEL 0.61
  • MBIN 0.45
  • Stochastic Oscillator
  • VCEL 58.40
  • MBIN 91.20

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and Banking segment that provides a wide range of financial products and services to consumers and businesses, including commercial and other consumer loan products.

Share on Social Networks: